NCT01077765View on ClinicalTrials.gov

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2009

Conditions
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Interventions
DEVICE

Eutrophill

Polyacrylamide Hydrogel

Trial Locations (1)

75015

Hopital europeen Georges Pompidou, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01077765 - Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy | Biotech Hunter | Biotech Hunter